| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue |
-
|
-
| | Cost of Revenue |
-
|
-
| | | Gross Profit |
-
|
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 5,717 | 2,963 | | Non Recurring |
-
|
-
| | Others | 67 | 19 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (5,784) | (2,982) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 338 | 630 | | Earnings Before Interest And Taxes | (5,446) | (2,345) | | Interest Expense |
-
|
-
| | Income Before Tax | (5,446) | (2,345) | | Income Tax Expense | 13 | 39 | | Minority Interest | 12 | 7 | | | | Net Income From Continuing Ops | (5,447) | (2,384) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (5,447) | (2,384) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($5,447) | ($2,384) |
|
0.02% Nasdaq 
Income Statement
